Abstract
Cell membrane microparticles (MPs) are phospholipid microvesicles shed from the plasma membrane of most eukaryotic cells undergoing activation or apoptosis. The presence of MPs is common in healthy individuals. However, an increase in their release is a controlled event and is considered a hallmark of cellular alteration. Microparticles display cell surface proteins that indicate their cellular origin. In addition, they may also express other markers, e.g., markers of cellular activation. Elevated levels of circulating MPs are associated with various vascular pathologies and their pathogenic potential has been widely documented. MPs have been analyzed in plasma and cell cultures by means of flow cytometry or solid phase assays. Here we present a three-color flow cytometric assay for immunophenotyping of MPs in plasma. This assay has been used to study elevated counts of different phenotypes of circulating endothelial MPs in several hematological and vascular diseases. A modified version of this assay can also be, used for MP analysis in blood products and cell cultures.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Simak, J., and Gelderman, M. P. (2006) Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus. Med. Rev. 20, 1–26.
Nomura, S. (2001) Function and clinical significance of platelet-derived microparticles. Int. J. Hematol. 74, 397–404.
Horstman, L. L., Jy, W., Jimenez, J. J., and Ahn, Y. S. (2004) Endothelial microparticles as markers of endothelial dysfunction. Front Biosci. 9, 1118–1135.
Greenwalt, T. J. (2006) The how and why of exocytic vesicles. Transfusion 46, 143–152.
Freyssinet, J. M. (2003) Cellular microparticles: what are they bad or good for? J. Thromb. Haemost. 1, 1655–1662.
Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F., and Freyssinet, J. M. (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler. Thromb. Vasc. Biol. 26, 2594–2604.
Martinez, M. C., Tesse, A., Zobairi, F., and Andriantsitohaina, R. (2005) Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am. J. Physiol. Heart Circ. Physiol. 288, H1004–1009.
Ahn, Y. S., Jy, W., Jimenez, J. J., and Horstman, L. L. (2004) More on cellular microparticles: what are they bad or good for? J. Thromb. Haemost. 2, 1215–1216.
Diamant, M., Tushuizen, M. E., Sturk, A., and Nieuwland, R. (2004) Cellular microparticles: new players in the field of vascular disease? Eur. J. Clin. Invest. 34, 392–401.
Distler, J. H., Huber, L. C., Gay, S., Distler, O., and Pisetsky, D. S. (2006) Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 39, 683–690.
Hugel, B., Martinez, M. C., Kunzelmann, C., and Freyssinet, J. M. (2005) Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20, 22–27.
Morel, O., Toti, F., Hugel, B., and Freyssinet, J. M. (2004) Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol. 11, 156–164.
Simak, J., Holada, K., D’Agnillo, F., Janota, J., and Vostal, J. G. (2002) Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma. Transfusion 42, 334–342.
Simak, J., Holada, K., Risitano, A. M., Zivny, J. H., Young, N. S., and Vostal, J. G. (2004) Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br. J. Haematol. 125, 804–813.
Simak, J., Gelderman, M. P., Yu, H., Wright, V., and Baird, A. E. (2006) Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J. Thromb. Haemost. 4, 1296–1302.
Simak, J., Holada, K., and Vostal, J. G. (2002) Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin. BMC Cell Biol. 3, 11.
Gelderman, M. P., Carter, L. B., and Simak, J. (2004) High counts of potentially pathogenic cell membrane microparticles in apheresis platelets. Blood 104, 988a.
Horstman, L. L., Jy, W., Jimenez, J. J., Bidot, C., and Ahn, Y. S. (2004) New horizons in the analysis of circulating cell-derived microparticles. Keio. J. Med. 53, 210–230.
Nieuwland, R., Berckmans, R. J., McGregor, S., Boing, A. N., Romijn, F. P., Westendorp, R. G., Hack, C. E., and Sturk, A. (2000) Cellular origin and procoagulant properties of microparticles in meningococcal, sepsis. Blood 95, 930–935.
Combes, V., Simon, A. C., Grau, G. E., Arnoux, D., Camoin, L., Sabatier, F., Mutin, M., Sanmarco, M., Sampol, J., and Dignat-George, F. (1999) In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest. 104, 93–102.
Mallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J. M., and Tedgui, A. (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101, 841–843.
Berckmans, R. J., Neiuwland, R., Boing, A. N., Romijn, F. P., Hack, C. E., and Sturk, A. (2001) Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost. 85, 639–646.
Shet, A. S., Aras, O., Gupta, K., Hass, M. J., Rausch, D. J., Saba, N., Koopmeiners, L., Key, N. S., and Hebbel, R. P. (2003) Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 102, 2678–2683.
Jimenez, J. J., Jy, W., Mauro, L. M., Horstman, L. L., and Ahn, Y. S. (2001) Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br. J. Haematol. 112, 81–90.
Jimenez, J. J., Jy, W., Mauro, L. M., Horstman, L. L., Soderland, C., and Ahn, Y. S. (2003) Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br. J. Haematol. 123, 896–902.
Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Croce, K., Furie, B. C., and Furie, B. (2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J. Exp. Med. 197, 1585–1598.
Taylor, D. D., and Gercel-Taylor, C. (2005) Tumor-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92 305–311.
Ogura, H., Tanaka, H., Koh, T., Fujita, K., Fujimi, S., Nakamori, Y., Hosotsubo, H., Kuwagata, Y., Shimazu, T., and Sugimoto, H. (2004) Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. J. Trauma 56, 823–830; discussion 830–831.
Sabatier, F., Roux, V., Anfosso, F., Camoin, L., Sampol, J., and Dignat-George, F. (2002) Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood. 99, 3962–70.
Brogan, P. A., and Dillon, M. J. (2004) Endothelial microparticles and the diagnosis of the vasculitides. Intern. Med. 43, 1115–1119.
Diamant, M., Nieuwland, R., Pablo, R. F., Sturk, A., Smit, J. W., and Radder, J. K. (2002) Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation. 106, 2442–2447.
Chou, J., Mackman, N., Merrill-Skoloff, G., Pedersen, B., Furie, B. C., and Furie, B. (2004) Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104, 3190–3197.
Aras, O., Shet, A., Bach, R. R., Hysjulien, J. L., Slungaard, A., Hebbel, R. P., Escolar, G., Jilma, B., and Key, N. S. (2004) Induction of microparticle-and cell-associated intravascular tissue factor in human endotoxemia. Blood 103, 4545–4553.
Abid Hussein, M. N., Meesters, E. W., Osmanovic, N., Romijn, F. P., Nieuwland, R., and Sturk, A. (2003) Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J. Thromb. Haemost. 1, 2434–2443.
Bernal-Mizrachi, L., Jy, W., Jimenez, J. J., Pastor, J., Mauro, L. M., Horstman, L. L., de Marchena, E., and Ahn, Y. S. (2003) High levels of circulating endothelial microparticles in patients with acute coronary syndromes Am. Heart. J. 145, 962–970.
Minagar, A., Jy, W., Jimenez, J. J., Sheremata, W. A., Mauro, L. M., Mao, W. W., Horstman, L. L., and Ahn, Y. S. (2001) Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56, 1319–1324.
Preston, R. A., Jy, W., Jimenez, J. J., Mauro, L. M., Horstman, L. L., Valle, M. Aime, G., and Ahn, Y. S. (2003) Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41, 211–217.
Perez-Pujol, S., Marker, P. H., and Key, N. S. (2007) Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry Part A 71A, 38–45.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, Totowa, NJ
About this protocol
Cite this protocol
Gelderman, M.P., Simak, J. (2008). Flow Cytometric Analysis of Cell Membrane Microparticles. In: Thompson, J.D., Ueffing, M., Schaeffer-Reiss, C. (eds) Functional Proteomics. Methods in Molecular Biology, vol 484. Humana Press. https://doi.org/10.1007/978-1-59745-398-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-59745-398-1_6
Publisher Name: Humana Press
Print ISBN: 978-1-58829-971-0
Online ISBN: 978-1-59745-398-1
eBook Packages: Springer Protocols